Published in J Affect Disord on June 29, 2007
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
Catatonia in obsessive-compulsive disorder: etiopathogenesis, differential diagnosis, and clinical management. Cogn Behav Neurol (2007) 2.02
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry (2003) 1.77
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry (2002) 1.63
Personality traits spectrum in panic disorder and major depression. Rev Bras Psiquiatr (2007) 1.43
Clinical subtypes of obsessive-compulsive disorder based on the presence of checking and washing compulsions. Rev Bras Psiquiatr (2005) 1.39
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry (2002) 1.38
Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J Affect Disord (2007) 1.21
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry (2002) 1.19
The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.12
Psychiatric disorders in asthmatic outpatients. Psychiatry Res (2002) 1.03
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci (2012) 1.02
Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Arch Gen Psychiatry (2002) 0.97
Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. J Clin Psychopharmacol (2002) 0.97
Panic disorder and control of breathing. Respir Physiol Neurobiol (2008) 0.93
The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10. Psychopathology (2009) 0.92
An update on the pharmacological treatment of obsessive-compulsive disorder. Expert Opin Pharmacother (2007) 0.89
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. Eur Arch Psychiatry Clin Neurosci (2011) 0.88
Freezing reaction in panic disorder patients associated with anticipatory anxiety. Depress Anxiety (2009) 0.87
Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit. Clinics (Sao Paulo) (2009) 0.87
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci (2008) 0.87
Early- and late-onset obsessive-compulsive disorder in adult patients: an exploratory clinical and therapeutic study. J Psychiatr Res (2003) 0.87
Quality of life and symptom dimensions of patients with obsessive-compulsive disorder. Psychiatry Res (2010) 0.86
Asperger Syndrome, obsessive-compulsive disorder, and major depression in a patient with 45,X/46,XY mosaicism. Psychopathology (2004) 0.86
A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam. Psychiatry Res (2005) 0.86
A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. J Clin Psychopharmacol (2012) 0.85
A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil. Int J Psychiatry Med (2006) 0.85
Imipramine on the treatment of chronic dizziness and panic disorder--3 cases report. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.85
Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res (2009) 0.84
Nomophobia: the mobile phone in panic disorder with agoraphobia: reducing phobias or worsening of dependence? Cogn Behav Neurol (2010) 0.84
Caffeine challenge test in panic disorder and depression with panic attacks. Compr Psychiatry (2007) 0.84
[Guidelines of the Brazilian Medical Association for the diagnosis and differential diagnosis of social anxiety disorder]. Rev Bras Psiquiatr (2010) 0.83
Psychopathological description of hyperventilation-induced panic attacks: a comparison with spontaneous panic attacks. Psychopathology (2004) 0.83
Virtual reality as a mechanism for exposure therapy. World J Biol Psychiatry (2010) 0.82
Impulse control disorders in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci (2005) 0.82
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci (2011) 0.82
EEG frontal asymmetry in the depressed and remitted elderly: is it related to the trait or to the state of depression? J Affect Disord (2010) 0.81
Demographic and clinical features of schizoaffective (schizobipolar) disorder--a 5-year retrospective study. Support for a bipolar spectrum disorder. J Affect Disord (2005) 0.81
Panic disorder respiratory subtype: a comparison between responses to hyperventilation and CO2 challenge tests. Psychiatry Res (2007) 0.80
A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls. Depress Anxiety (2008) 0.80
[Neuroanatomy of panic disorder]. Rev Bras Psiquiatr (2004) 0.80